$BBLR
Bubblr Inc. Stock $bblr

$bblr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000166357723000246 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.285M	$328.8K
YoY Change	2009.12%
% of Gross Profit
Research & Development	$52.12K	$39.15K
YoY Change	-1.09%
% of Gross Profit
Depreciation & Amortization	$3.106K	$3.106K	$4.223K
YoY Change		-26.45%
% of Gross Profit
Operating Expenses	$1.790M	$202.0K
YoY Change	-27.91%
Operating Profit	-$1.790M	-$202.0K
YoY Change	-27.91%
Interest Expense	$617.00	$1.129K
YoY Change	-97.97%
% of Operating Profit
Other Income/Expense, Net	$86.63K	-$52.38K
YoY Change	-30.06%
Pretax Income	-$1.703M	-$254.3K
YoY Change	-27.8%
Income Tax
% Of Pretax Income
Net Earnings	-$1.703M	-$254.3K	-$1.030M
YoY Change	-27.8%	-75.32%	-19.77%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	$0.00
Diluted Earnings Per Share	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	156.3M shares	155.7M shares
Diluted Shares Outstanding	156.3M shares	154.9M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$5.507K	$35.12K	$93.49K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$6.240K
Other Receivables	$7.741K
Total Short-Term Assets	$13.25K	$41.36K
YoY Change	-90.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.87K	$45.80K
YoY Change	-20.0%
Goodwill
YoY Change
Intangibles	$1.284M	$32.46K
YoY Change	3947.05%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.328M	$1.352M
YoY Change	-1.99%
TOTAL ASSETS
Total Short-Term Assets	$13.25K	$41.36K
Total Long-Term Assets	$1.328M	$1.352M
Total Assets	$1.341M	$1.393M
YoY Change	-10.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$194.0K	$394.0K
YoY Change	43.24%
Accrued Expenses	$834.4K	$96.33K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.795M	$1.139M
YoY Change	192.54%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$757.4K	$814.9K
YoY Change	-72.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.795M	$1.139M
Total Long-Term Liabilities	$757.4K	$814.9K
Total Liabilities	$2.552M	$1.954M
YoY Change	-23.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.88M	-$13.15M
YoY Change	26.13%
Common Stock	$1.569M	$1.559M
YoY Change	-0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.211M	-$560.5K	-$1.684M
YoY Change
Total Liabilities & Shareholders Equity	$1.341M	$1.393M
YoY Change	-10.27%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.703M	-$254.3K	-$1.030M
YoY Change	-27.8%	-75.32%	-19.77%
Depreciation, Depletion And Amortization	$3.106K	$3.106K	$4.223K
YoY Change		-26.45%
Cash From Operating Activities		-$158.4K	-$404.3K
YoY Change		-60.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$11.14K	-$11.68K
YoY Change		-4.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$203.1K	$399.8K
YoY Change		-49.2%
NET CHANGE
Cash From Operating Activities		-$158.4K	-$404.3K
Cash From Investing Activities		-$11.14K	-$11.68K
Cash From Financing Activities		$203.1K	$399.8K
Net Change In Cash		$2.582K	$30.53K
YoY Change		-91.54%
FREE CASH FLOW
Cash From Operating Activities		-$158.4K	-$404.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001873722
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	BBLR	Share Based Finance Incentive ShareBasedFinanceIncentive		usd
CY2022Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures		usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	BBLR	Warrant Liability WarrantLiability		usd
CY2022Q1	BBLR	Stock Issued During Period For Series C Preferred Dividend Amount StockIssuedDuringPeriodForSeriesCPreferredDividendAmount		usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2023Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative		usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	333-260902
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Bubblr, Inc.
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2355916
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	21 West 46th Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10036
CY2023Q1	dei	City Area Code CityAreaCode	646
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	814 7184
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	156261278	shares
CY2023Q1	us-gaap	Cash Cash	35115	usd
CY2022Q4	us-gaap	Cash Cash	32533	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6240	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9884	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	41355	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	42417	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45800	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47956	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1306093	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1325995	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1351893	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1373951	usd
CY2023Q1	us-gaap	Assets Assets	1393248	usd
CY2022Q4	us-gaap	Assets Assets	1416368	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	393973	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	141605	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	96331	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50094	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	12225	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	11987	usd
CY2023Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	636261	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	392170	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1138790	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	595856	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	8205	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	10465	usd
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable	535709	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	525291	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	270998	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	198479	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	814912	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	734235	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1953702	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1330091	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155948778	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154309318	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1559488	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1543093	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10638631	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11006607	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13151445	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12875437	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	392871	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	412013	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-560454	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1393248	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1416368	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47625	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11119	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	-225570	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	192829	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	312463	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	37593	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	-31336	usd
CY2021	us-gaap	Officers Compensation OfficersCompensation	140944	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59627	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	107595	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39152	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61261	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	201961	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	551341	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-201961	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-551341	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	98	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	452	usd
CY2022	us-gaap	Interest Expense InterestExpense	1129	usd
CY2021	us-gaap	Interest Expense InterestExpense	414844	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-72519	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-23891	usd
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	-21175	usd
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	40707	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-52375	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-478990	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-254336	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1030331	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-254336	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1030331	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-19142	usd
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	13373	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-19142	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13373	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-273478	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1016958	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022	BBLR	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	154904171	shares
CY2021	BBLR	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	140499144	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1127590	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	75460	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8980	usd
CY2022Q1	BBLR	Stock Issued During Period Equity Finance Agreement Value StockIssuedDuringPeriodEquityFinanceAgreementValue	379814	usd
CY2022Q1	BBLR	Dividend Series C Preferred Stock DividendSeriesCPreferredStock	-3272	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1030331	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13373	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1683566	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	285338	usd
CY2023Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	-659052	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	22133	usd
CY2023Q1	BBLR	Dividend Series C Preferred Stock DividendSeriesCPreferredStock	-21672	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-254336	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-19142	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-560454	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-254336	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1030331	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	285338	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	84440	usd
CY2022Q1	BBLR	Share Based Finance Incentive ShareBasedFinanceIncentive	379814	usd
CY2023Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	-659052	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Oci FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci	-72519	usd
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Oci FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci	-23891	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	22429	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56521	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101193	usd
CY2023Q1	us-gaap	Depreciation Depreciation	3106	usd
CY2022Q1	us-gaap	Depreciation Depreciation	4223	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3778	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2581	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3156	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10985	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	336901	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3523	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-158381	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-404298	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11138	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11684	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11138	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11684	usd
CY2023Q1	us-gaap	Payments For Loans PaymentsForLoans	2430	usd
CY2022Q1	us-gaap	Payments For Loans PaymentsForLoans	3322	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18228	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	52556	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	223777	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	19709	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	421000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	203119	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399831	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31018	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46676	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2582	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	30525	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32533	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62967	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35115	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93492	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	4774	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5712	usd
CY2022Q1	BBLR	Warrant Liability WarrantLiability	449043	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	21672	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3272	usd
CY2023Q1	BBLR	Stock Issued During Period For Series C Preferred Dividend Amount StockIssuedDuringPeriodForSeriesCPreferredDividendAmount	22133	usd
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-10-22
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-273478	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13151445	usd
CY2023Q1	BBLR	Liabilities Current In Excess Of Assets Current LiabilitiesCurrentInExcessOfAssetsCurrent	1097435	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zwXodSio4dyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	270998	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	198479	usd
CY2023Q1	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_848_eus-gaap--DerivativesReportingOfDerivativeActivity_zywEsuwpO1C4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Common Stock Purchase Warrants and Derivative Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p>
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5306870	shares
CY2023Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.2341	pure
CY2022Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.3139	pure
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.2101	pure
CY2023Q1	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2152	pure
CY2022Q1	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.3412	pure
CY2022Q4	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	1.2430	pure
CY2023Q1	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	21175	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	40707	usd
CY2015Q2	BBLR	Taxable Diverted Profits Tax Percentage TaxableDivertedProfitsTaxPercentage	0.25	pure
CY2023Q1	us-gaap	Deposits Deposits	200	usd
CY2022Q4	us-gaap	Deposits Deposits	200	usd
CY2023Q1	us-gaap	Accounts Receivable From Securitization AccountsReceivableFromSecuritization	6040	usd
CY2022Q4	us-gaap	Accounts Receivable From Securitization AccountsReceivableFromSecuritization	9684	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6240	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9884	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	85617	usd
CY2023Q1	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	0	usd
CY2023Q1	BBLR	Effects Of Foreign Currency Translation Property Equipment EffectsOfForeignCurrencyTranslationPropertyEquipment	1697	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	87314	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37661	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	3106	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	747	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41514	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45800	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47956	usd
CY2023Q1	us-gaap	Depreciation Depreciation	3106	usd
CY2022Q1	us-gaap	Depreciation Depreciation	4223	usd
CY2023Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	32457	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	31826	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	168300	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	31826	usd
CY2022Q4	us-gaap	Capitalized Costs Proved Properties CapitalizedCostsProvedProperties	45745	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3010069	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	11138	usd
CY2023Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	182775	usd
CY2023Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	32457	usd
CY2023Q1	us-gaap	Capitalized Costs Proved Properties CapitalizedCostsProvedProperties	45745	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3079997	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1684074	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56521	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Translation And Purchase Accounting Adjustments FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments	33309	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1773904	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1306093	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1325995	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	11138	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	11684	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56521	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101193	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	122326	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	163100	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	163100	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	163100	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	163100	usd
CY2023Q1	BBLR	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	163100	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	335810	usd
CY2023Q1	BBLR	Finite Lived Intangible Assets Accumulated Amortization Total FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal	1273636	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3143	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	21672	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	22133	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	74659	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24818	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	96331	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50094	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	12225	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	11987	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	8205	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	10465	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2430	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	3322	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	7403	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	9870	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	17273	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	-3157	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	20430	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	12225	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	8205	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	177	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.20	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0833	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	1.50	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0473	pure
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	198479	usd
CY2023Q1	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	72519	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	270998	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	721000	usd
CY2022	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-28043	usd
CY2022	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	494753	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	198479	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-28043	usd
CY2023Q1	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	95768	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	903	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155948778	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154309318	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.32
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y3M7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.32
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.32
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y7D
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.32
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.32
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q1	BBLR	Vesting Of Deferred Stock Based Compensation VestingOfDeferredStockBasedCompensation	659052	usd
CY2023Q1	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	1600548	usd
CY2023Q1	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	1600548	usd
CY2023Q1	BBLR	Deferred Compensation Equity Reversed DeferredCompensationEquityReversed	659052	usd

Files In Submission

Name	View Source	Status
0001663577-23-000246-index-headers.html	Edgar Link	pending
0001663577-23-000246-index.html	Edgar Link	pending
0001663577-23-000246.txt	Edgar Link	pending
0001663577-23-000246-xbrl.zip	Edgar Link	pending
bblr-20230331.xsd	Edgar Link	pending
bblr10q_033123.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
bblr-20230331_def.xml	Edgar Link	unprocessable
bblr-20230331_pre.xml	Edgar Link	unprocessable
bblr-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bblr10q_033123_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bblr-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBLR
Bubblr Inc. Stock $bblr

2023 Q2 Form 10-Q Financial Statement

#000166357723000246 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR Bubblr Inc. Stock $bblr

2023 Q2 Form 10-Q Financial Statement

#000166357723000246 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR
Bubblr Inc. Stock $bblr